MECOM and ovarian carcinoma: Screening for potential epidrugs with MECOM-modulatory function identified E-JIB-04 as a potent inhibitor with growth inhibitory properties and the ability to enhance cisplatin sensitivity of ovarian cancer cells harboring MECOM amplification.